Video/New Hepatitis C Drug Sovaldi

A new pill could help cure the more than 3.2 million people in the U.S. who are infected with hepatitis C, a virus that can cause a chronic infection, leading to liver disease, and sometimes, liver cancer. It’s the No. 1 blood-borne infection in the United States. But at $1,000 a pill, the new treatment could cost $84,000 for a 12-week regimen, making it inaccessible for many patients.